KRYS — Krystal Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapHigh Flyer

Annual balance sheet for Krystal Biotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	271	438	379	532	598
Net Total Accounts Receivable
Net Total Receivables	—	—	—	42	105
Total Inventory
Prepaid Expenses
Total Current Assets	275	442	384	588	742
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	34.2	120	170	168	161
Long Term Investments
Other Long Term Assets
Total Assets	311	626	558	818	1,056
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	15.5	25.7	28.8	33.1	102
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	18.8	32.7	36.2	39.7	109
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	292	594	522	779	946
Total Liabilities & Shareholders' Equity	311	626	558	818	1,056
Total Common Shares Outstanding